Carl Zeiss Meditec AG

ETR-AFX
Deutsche Börse Xetra
Healthcare Medical Instruments & Supplies
Global Rank
#3473
Country Rank
#77
Market Cap
4.69 B
Price
53.59
Change (%)
4.89%
Volume
200,321

Carl Zeiss Meditec AG's latest marketcap:

4.69 B

As of 08/02/2025, Carl Zeiss Meditec AG's market capitalization has reached $4.69 B. According to our data, Carl Zeiss Meditec AG is the 3473th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 4.69 B
Revenue (ttm) 2.51 B
Net Income (ttm) 180.57 M
Shares Out 87.54 M
EPS (ttm) 2.05
Forward PE 21.41
Ex-Dividend Date 03/27/2025
Earnings Date 08/07/2025
Market Cap Chart
Data Updated: 08/02/2025

Carl Zeiss Meditec AG's yearly market capitalization.

Carl Zeiss Meditec AG has seen its market value grow from €1.72 B to €4.05 B since 2014, representing a total increase of 136.03% and an annual compound growth rate (CAGR) of 8.45%.
Date Market Cap(€) Market Cap(USD) Change (%) Global Rank
08/02/2025 €4.05 B $4.69 B 1.63% 3473
12/30/2024 €3.98 B $4.12 B -54.93% 3434
12/29/2023 €8.84 B $9.76 B -16.17% 1659
12/30/2022 €10.55 B $11.29 B -36.22% 1369
12/30/2021 €16.53 B $18.79 B 69.74% 1061
12/30/2020 €9.74 B $11.9 B -4.22% 1393
12/30/2019 €10.17 B $11.4 B 66.47% 1175
12/28/2018 €6.11 B $7 B 31.96% 1549
12/29/2017 €4.63 B $5.55 B 62.67% 2149
12/30/2016 €2.85 B $2.99 B 22.59% 2920

Company Profile

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a leading medical technology company based in Jena, Germany, with operations across Europe, North America, and Asia. Founded in 1846, it is a subsidiary of Carl Zeiss AG and specializes in innovative solutions for ophthalmology and microsurgery.

Business Segments

The company operates in two key segments:

  • Ophthalmology: Provides products and solutions for diagnosing and treating chronic eye diseases, including:
    • Devices for general eye examinations (slit lamps, refractometers, tonometers)
    • Optical coherence tomography (OCT) devices and fundus cameras
    • Surgical equipment (microscopes, phacoemulsification, vitrectomy devices)
    • Intraocular lenses and laser eye surgery systems
  • Microsurgery: Offers solutions for invasive surgical treatments in ENT, plastic/reconstructive, neuro, dental, and spinal surgeries.

Customer Base

Carl Zeiss Meditec serves physicians and hospitals worldwide, delivering advanced medical technologies to improve patient care.

Frequently Asked Questions

  • What is Carl Zeiss Meditec AG's (ETR-AFX) current market cap?
    As of 08/02/2025, Carl Zeiss Meditec AG (including the parent company, if applicable) has an estimated market capitalization of $4.69 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Carl Zeiss Meditec AG global market capitalization ranking is approximately 3473 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.